Holen Sie sich die Stockscreener-App
78.40
0.51%
0.40
Handel nachbörslich:
77.99
-0.41
-0.52%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$78.00
Offen:
$77.61
24-Stunden-Volumen:
2.46M
Relative Volume:
0.67
Marktkapitalisierung:
$30.74B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$571.50M
KGV:
54.44
EPS:
1.44
Netto-Cashflow:
$570.80M
1W Leistung:
+5.52%
1M Leistung:
-0.58%
6M Leistung:
+0.72%
1J Leistung:
+12.47%
1-Tages-Spanne:
$77.61
$79.20
1-Wochen-Bereich:
$74.00
$81.64
52-Wochen-Spanne:
$57.52
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Firmenname
Dexcom Inc
Sektor
Branche
Telefon
(858) 200-0200
Adresse
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Vergleichen Sie DXCM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
78.40 | 30.59B | 4.30B | 571.50M | 570.80M | 1.44 |
|
ABT
Abbott Laboratories
|
131.95 | 230.09B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
108.09 | 160.24B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.76 | 150.29B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.07 | 119.28B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
79.80 | 47.09B | 5.69B | 1.41B | 577.90M | 6.95 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Eingeleitet | Argus | Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Buy |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-02-03 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-03-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-01-26 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-15 | Eingeleitet | Bernstein | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-03 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-18 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-01-06 | Hochstufung | UBS | Neutral → Buy |
| 2020-10-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-11-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-11-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-10-23 | Eingeleitet | Stifel | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-10-19 | Hochstufung | Goldman | Sell → Neutral |
| 2018-09-12 | Hochstufung | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Bestätigt | Canaccord Genuity | Buy |
| 2018-07-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Eingeleitet | BofA/Merrill | Buy |
| 2018-05-03 | Bestätigt | Canaccord Genuity | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Sell |
| 2018-04-04 | Eingeleitet | Guggenheim | Neutral |
| 2018-03-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Bestätigt | Wedbush | Outperform |
Alle ansehen
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
After 30 years, Vancouver Ad Agency Wasserman Unveils New Identity as 9Letters - GlobeNewswire Inc.
How Is DexCom's Performance Compared to Other Medical Device Companies? - MSN
DexCom Faces Organic Issues, Competition Threat Despite 'Doing Everything' to Topple Headwinds, Oppenheimer Says - MarketScreener
Why DexCom (DXCM) Shares Are Sliding Today - Yahoo Finance
Oppenheimer Downgrades DexCom to Perform From Outperform, Removes $102 Price Target - MarketScreener
Can Traders Expect Breakout From DexCom Inc. This WeekWeekly Gains Report & Free Safe Capital Growth Stock Tips - beatles.ru
What is DexCom Inc. s P E ratio telling us2025 Price Targets & Pattern Based Trade Signal System - beatles.ru
Buyback Watch: Can DexCom Inc. benefit from deglobalizationQuarterly Trade Summary & Growth Oriented Trade Recommendations - 강소기업뉴스
Should I average down on DexCom Inc. stock2025 Biggest Moves & Fast Moving Stock Trade Plans - خودرو بانک
DexCom Faces Evaluation Adjustment Amid Strong Financial Performance and Quality Concerns - Markets Mojo
What the charts say about DexCom Inc. todayJuly 2025 Analyst Calls & Low Risk Investment Opportunities - Newser
Can trapped investors hope for a rebound in DexCom Inc.Day Trade & Technical Pattern Based Signals - Newser
What recovery options are there for DexCom Inc.Market Risk Analysis & Accurate Entry and Exit Point Alerts - Newser
What momentum shifts mean for DexCom Inc.Portfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser
Using RSI to spot recovery in DexCom Inc.Earnings Recap Report & Smart Money Movement Tracker - Newser
Analyzing DexCom Inc. with risk reward ratio chartsBull Run & Safe Capital Growth Stock Tips - Newser
Ranking DexCom Inc. among high performing stocks via toolsWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Using data filters to optimize entry into DexCom Inc.July 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
How to monitor DexCom Inc. with trend dashboardsOptions Play & AI Powered Market Entry Strategies - Newser
Dexcom shares fall 1.19% after-hours as insider sells $357,796 worth of shares. - AInvest
Assessing the Impact of Insider Share Sales on Investor Confidence in Dexcom (DXCM) - AInvest
Dealogic: DEXCOM INC EVP Jereme Sells 4824 Shares at $74.17/Share on 2025-09-02 - AInvest
Dexcom to lay off about 350 people - MedTech Dive
Why DexCom (DXCM) Stock Is Up Today - TradingView
Will DexCom Inc. outperform tech stocks2025 Volatility Report & Capital Efficiency Focused Ideas - خودرو بانک
Dexcom, Inc. shares rise 3.35% intraday after positive presentation at Wells Fargo 20th. - AInvest
Understanding DexCom Inc.’s price movementGap Down & Risk Adjusted Buy and Sell Alerts - Newser
Market reaction to DexCom Inc.’s recent newsPortfolio Risk Report & AI Driven Price Forecasts - Newser
Applying Wyckoff theory to DexCom Inc. stockWeekly Stock Analysis & Verified Chart Pattern Signals - Newser
Signal strength of DexCom Inc. stock in tech scannersJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Is DexCom Inc. backed by strong institutional buyingDollar Strength & Real-Time Sentiment Analysis - خودرو بانک
Calif. biotech company Dexcom lays off hundreds amid shift to Arizona - SFGATE
DexCom at Wells Fargo Conference: Strategic Growth Plans - Investing.com
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Transcript : DexCom, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 02 - MarketScreener
Dexcom shares jump, up 4.9%, a session high - AInvest
What data driven models say about DexCom Inc.’s future2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-03 08:54:41 - Newser
How to recover losses in DexCom Inc. stockWeekly Market Report & Comprehensive Market Scan Reports - Newser
Will DexCom's (DXCM) Latest Investor Update Hint at a Shifting Innovation Strategy? - simplywall.st
Analyzing drawdowns of DexCom Inc. with statistical toolsTrade Risk Assessment & High Conviction Buy Zone Alerts - Newser
Custom watchlist performance reports with DexCom Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
Tools to assess DexCom Inc.’s risk profileWeekly Profit Summary & Safe Entry Trade Reports - Newser
What candlestick patterns are forming on DexCom Inc.2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Exit strategy if you’re trapped in DexCom Inc.July 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
Published on: 2025-09-03 23:05:34 - Newser
Custom watchlist performance reports with DexCom IncMarket Performance Report & Fast Moving Stock Watchlists - Newser
Stock Analysis | Dexcom OutlookWeak Technicals and Mixed Analyst Sentiment - AInvest
Should you hold or exit DexCom Inc. nowTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Dexcom Trails Medtronic in Diabetes Tech Race as $330M Volume Marks 343rd Market Rank - AInvest
Finanzdaten der Dexcom Inc-Aktie (DXCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.01%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):